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LETTER TO THE EDITOR
Two Novel Mutations in the Keratin 1 Gene in Epidermolytic
Hyperkeratosis
To the Editor:
Epidermolytic hyperkeratosis (EHK, MIM113800) is a rare auto-
somal dominant genodermatosis, although many cases occur spor-
adically as new mutations. It is characterized by blistering and
erythema at birth, and development of hyperkeratosis with increas-
ing age. Ultrastructural analyses reveal clumping of the keratin
intermediate ®laments (KIF) within suprabasal keratinocytes of the
epidermis. Previous studies have demonstrated that EHK is caused
by mutations in the genes encoding the keratin 1 (K1) or the K10
proteins (Cheng et al, 1992; Chipev et al, 1992; Rothnagel et al,
1992; McLean and Lane, 1995; Korge and Krieg, 1996). Clinically,
EHK has been divided into the palmoplantar type (palm sole, PS)
and the nonpalmoplantar type (nonpalm sole), and each type has
been subdivided into three subtypes according to the nature and
severity of scaling (DiGiovanna and Bale, 1994; DiGiovanna et al,
1998). The mutation/clinical phenotype correlations available
suggest that the PS and nonpalm sole types are due primarily to
mutations in the KRT1 and KRT10 genes, respectively. The more
severe PS-1 and PS-2 cases are caused by mutations that change
sequences encoding the beginning of the 1A rod domain segment, or
towards the end of the 2B rod domain segment (Yang et al, 1994,
1999; Arin et al, 1999, 2000; Cserhalmi-Friedman et al, 2000). In this
study, we describe two separate cases of EHK, classi®ed as PS-2,
caused by two different novel mutations: Asn187Lys located in exon
1, which is the 8th residue of the 1A rod domain segment; and
Leu475Pro located in exon 7, which is the 10th residue from the end
of 2B rod domain segment of K1.
Two unrelated children, EHK-SJ and EHK-AS, have diffuse
thick keratoderma on both palms and soles as well as moderate scaly
patches on their entire bodies, but the morphology of their hair,
nails, and teeth are normal. Light microscopic examination revealed
vacuolar degeneration in the spinous and granular layers. As both
sets of parents were normal, these represent sporadic cases. Both
were classi®ed as having the PS-2 form of EHK. DNA was
extracted (Chipev et al, 1994; Yang et al, 1994) from both the
affected and unaffected family members, and from 50 unrelated
normal individuals used as controls.
Following sequencing of all exons of the KRT1 and KRT10
genes, patient EHK-SJ had a single nucleotide substitution on one
allele of codon 187 in exon 1 of the KRT1 gene (AAC to AAA) so
that the sequence gel of Fig 1(a) shows both the wild-type C and a
mutant A at nucleotide position 564 (GenBank NM-006121;
relative to the translation start point) in the proband. The mutant
allele encodes a lysine residue instead of a wild-type asparagine
residue in position 8 of the 1A rod domain segment. As this
nucleotide substitution does not create or destroy a restriction
enzyme site, we performed a polymerase chain reaction ampli®-
cation of a speci®c allele assay (Yang et al, 1994, 1999). As the
parents and 50 other unrelated normal controls do not have this
substitution, it represents a new mutation. The same mutation in
the KRT2e gene was reported in ichthyosis bullosa of Siemens
(Whittock et al, 2001). In patient EHK-AS, we found a single
nucleotide substitution on one allele of codon 475 in exon 7 of the
KRT1 gene (CTG to CCG) so that the sequence gel of Fig 1(b)
shows both a wild-type T and a mutant C at nucleotide position
1457 (GenBank NM-006121; relative to the translation start point)
in the proband. The mutant allele encodes a proline residue instead
of a wild-type leucine residue in position 113 of 2B rod domain
segment. This nucleotide substitution destroys an MspI restriction
enzyme site (C/CGG), which was used to con®rm that the
unaffected parents and 50 other unrelated unaffected persons do not
posses this new mutation.
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Figure 1. (a) EHK-SJ. DNA sequences showing C to A change
(arrow), which introduces an Asn187Lys amino acid substitution in
the 1A rod domain segment of K1. (b)EHK-AS. DNA sequences
showing T to C change (arrow), which introduces a Leu475Pro amino
acid substitution in the 2B rod domain segment of K1.
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Next, we synthesized four 18-residue peptides corresponding to
the beginning of the 1A and the end of 2B region of wild-type K1, or
sequences with the described amino acid substitutions, respectively.
These were used for an assay that uses synthetic peptides to interfere
with KIF assembly (Chipev et al, 1992): wild-type peptides
disassemble KIF, whereas peptides bearing identi®ed substitutions
caused by novel mutations often do not. In both cases, we found that
the wild-type 1A or 2B peptides interfered with the formation of
KIF in vitro; however, neither mutant peptide interfered with KIF
assembly (Fig 2). From this we can conclude that the substitutions
resulting from the observed mutations affect normal KIF structure.
The three-dimensional structures of the 1A (Strelkov et al, 2002) and
2B (Herrmann et al, 2000) domains of the related IF protein
vimentin have been solved. As the amino acid sequences of vimentin
and K1 are conserved in these regions, their structures are likely to be
similar. An asparagine residue in position 8 of the 1A domain has
been conserved in all IF proteins. Its side chain projects laterally
outward from the axis of the coiled-coil, where it presumably
interacts with residues on an adjacent molecule. Indeed, we have
predicted that this residue forms H-bonds with residues in the L2
linker region in the A11 alignment mode of two adjacent molecules
in the tetramer (Mehrani et al, 2001). By model building analyses, the
substitution of a larger positively charged lysine residue will interfere
with such interactions. Thus this Asn187Lys substitution in patient
EHK-SJ will likely severely interfere with KIF structure at the two-
molecule hierarchical stage of KIF assembly. Likewise, a leucine
residue in position 113 of the 2B rod domain segment has been
conserved in all IF chains. Based on the extant model of this region in
vimentin, this leucine residue marks the point at which the coiled-
coil 2B sequences unravel and fold back along the axis of the coiled-
coil. Insertion of an aberrant cis peptide bond of a proline residue at
this point will prevent this refold. Accordingly, the Leu475Pro
substitution will cause failed KIF assembly at the two-molecule level
of assembly.
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Figure 2. KIF disassembly assay using 18-residue wild-type 1A (b)
or 2B (d) peptides. In both cases, normal KIF (a) are disassembled into
small particles within 30 min at 23°; however, the Asn187Lys mutant 1A
peptide (c) or Leu475Pro mutant 2B peptide (e) had no discernible effect
on preformed KIF, or KIF assembly in vitro (not shown). The assay
suggests that the structure of the mutant portions of the proteins will
interfere with KIF assembly. Scale bar = 200 nm.
VOL. 119, NO. 4 OCTOBER 2002 LETTERS TO THE EDITOR 977
